European Commission Steps Further Towards ‘Ambitious’ Pharma Legislation Reform

Considering Proposals To Allow Earlier Market Entry For Generics And Biosimilars

 
• By Francesca Bruce
  
Touch the future,Interface technology, the future of user experience.
The European Commission Is Consulting On Ambitious Reform

More from Policy & Regulation

More from Generics Bulletin